US Stock MarketDetailed Quotes

DHR Danaher

Watchlist
  • 207.470
  • -1.970-0.94%
Trading Feb 27 09:51 ET
148.28BMarket Cap39.22P/E (TTM)

Danaher Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Danaher Q4 2024 Earnings Date

Currency：USDJan 29, 2025

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
6.49B
6.54B
+45.08M
Beat Est.
+1.37%
+2.08%
+0.69%
EPS
1.73
1.49
-0.24
Miss Est.
+19.19%
+2.76%
-13.79%
Analyst Rating
Buy

Feb 27, 2025

Danaher Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 22 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 5.803B--
--2025/Q1-- / 5.573B--
Jan 29, 20252024/Q46.538B / 6.493B--
Oct 22, 20242024/Q35.798B / 5.588B--
Jul 23, 20242024/Q25.743B / 5.585B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 5.803B--
--2025/Q1-- / 5.573B--
Jan 29, 20252024/Q46.538B / 6.493B--
Oct 22, 20242024/Q35.798B / 5.588B--
Jul 23, 20242024/Q25.743B / 5.585B--

Unlock Free Earnings Estimates

Danaher Earnings Reports

  • Danaher | 10-K: FY2024 Annual Report

    Feb 20 16:24 ET

  • Danaher | 8-K: Danaher Reports Fourth Quarter and Full Year 2024 Results

    Jan 29 13:41 ET

  • Danaher | 8-K: Danaher Reports Third Quarter 2024 Results

    Oct 22, 2024 16:01 ET

  • Danaher | 10-Q: Q3 2024 Earnings Report

    Oct 22, 2024 16:01 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
    DMZPY
    +2.78%
    Halozyme Therapeutics
    HALO
    +1.36%
    Hutchmed (China)
    HCM
    +1.14%
    Lantheus
    LNTH
    +1.02%
    Collegium Pharmaceutical
    COLL
    +0.25%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Feb 27, 2025

    Buy

    • Buy

      66.67%

    • Hold

      33.33%

    • Sell

      0.00%

    Price Target

    No Data